<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05066893</url>
  </required_header>
  <id_info>
    <org_study_id>2604</org_study_id>
    <nct_id>NCT05066893</nct_id>
  </id_info>
  <brief_title>Pediatric Boot Camp Program</brief_title>
  <official_title>Type 1 Diabetes Boot Camp Program: An Intensive Program to Improve Glycemic Control in Adolescents With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georgetown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Georgetown University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An intensive 13 weeks program that aims to improve glucose control in children with type 1&#xD;
      diabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our new PeDi-BoCa Program aims to help children with type 1 diabetes achieve better diabetes&#xD;
      control by interacting weekly with their doctor/nurse practitioner (NP) and also by using a&#xD;
      &quot;smart pen&quot; that can facilitate the burden of daily calculations with the use of an app on&#xD;
      the phone.&#xD;
&#xD;
      Your child's doctor/NP will be able to remotely monitor your child's glucose every week&#xD;
      (Dexcom) and make recommendations for changes, discuss solutions to possible obstacles and&#xD;
      offer intensive diabetes education.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2020</start_date>
  <completion_date type="Anticipated">November 5, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 5, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HbA1c</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Type 1 Diabetes</condition>
  <condition>Children, Only</condition>
  <arm_group>
    <arm_group_label>standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard of care will be given as per usual care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intensive monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intensive monitoring every week will be given to participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>telehealth visits</intervention_name>
    <description>intensive visits with doctor</description>
    <arm_group_label>intensive monitoring</arm_group_label>
    <arm_group_label>standard of care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 11-18 years old&#xD;
&#xD;
          2. HbA1c &gt; 8.5%&#xD;
&#xD;
          3. Duration of type 1 diabetes &gt;1 year&#xD;
&#xD;
          4. Child uses Dexcom and has a phone that is compatible with the InPen app and Dexcom&#xD;
             Clarity app.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Not able to attend telehealth visits&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medstar Pediatrics</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Runner</last_name>
      <phone>202-243-3560</phone>
      <phone_ext>5</phone_ext>
      <email>diabetes@georgetown.edu</email>
    </contact>
    <investigator>
      <last_name>Evgenia Gourgari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 23, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2021</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

